Herbert Smith Freehills Kramer

Intellectual Property

Daniel Williams litigates patent matters in both the life science and technology industries. In the life sciences, Daniel works on disputes involving small molecule and biologic drugs, drug delivery technology, and recombinant DNA technology. As a member of the trial team, Daniel recently represented a major pharmaceutical company in Hatch-Waxman litigation involving a blockbuster cancer therapy. Daniel has also worked on numerous patent cases involving computer security software.